Head and neck radiotherapy amid the COVID-19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
- Creators
- Alterio D.
- Volpe S.
- Bacigalupo A.
- Bonomo P.
- De Felice F.
- Dionisi F.
- D'Onofrio I.
- D'Angelo E.
- Di Rito A.
- Fanetti G.
- Franco P.
- Maddalo M.
- Merlotti A.
- Micciche F.
- Orlandi E.
- Paiar F.
- Ursino S.
- Pepa M.
- Corvo R.
- Di Muzio N. G.
- Magrini S. M.
- Russi E.
- Sanguineti G.
- Jereczek-Fossa B. A.
- Donato V.
- Musio D.
- Others:
- Alterio, D.
- Volpe, S.
- Bacigalupo, A.
- Bonomo, P.
- De Felice, F.
- Dionisi, F.
- D'Onofrio, I.
- D'Angelo, E.
- Di Rito, A.
- Fanetti, G.
- Franco, P.
- Maddalo, M.
- Merlotti, A.
- Micciche, F.
- Orlandi, E.
- Paiar, F.
- Ursino, S.
- Pepa, M.
- Corvo, R.
- Di Muzio, N. G.
- Magrini, S. M.
- Russi, E.
- Sanguineti, G.
- Jereczek-Fossa, B. A.
- Donato, V.
- Musio, D.
Description
Management of patients with head and neck cancers (HNCs) is challenging for the Radiation Oncologist, especially in the COVID-19 era. The Italian Society of Radiotherapy and Clinical Oncology (AIRO) identified the need of practice recommendations on logistic issues, treatment delivery and healthcare personnel's protection in a time of limited resources. A panel of 15 national experts on HNCs completed a modified Delphi process. A five-point Likert scale was used; the chosen cut-offs for strong agreement and agreement were 75% and 66%, respectively. Items were organized into two sections: (1) general recommendations (10 items) and (2) special recommendations (45 items), detailing a set of procedures to be applied to all specific phases of the Radiation Oncology workflow. The distribution of facilities across the country was as follows: 47% Northern, 33% Central and 20% Southern regions. There was agreement or strong agreement across the majority (93%) of proposed items including treatment strategies, use of personal protection devices, set-up modifications and follow-up re-scheduling. Guaranteeing treatment delivery for HNC patients is well-recognized in Radiation Oncology. Our recommendations provide a flexible tool for management both in the pandemic and post-pandemic phase of the COVID-19 outbreak.
Additional details
- URL
- http://hdl.handle.net/11567/1020218
- URN
- urn:oai:iris.unige.it:11567/1020218
- Origin repository
- UNIGE